Add to ORKGAmong the several merits that must be ascribed to the Revised European–American Lymphoma (REAL) classification [1], the most relevant from a therapeutic standpoint is that it has ulti-mately allowed clinicians all over the world to fully compare th
Therapy of the lymphomas is predominantly nonoperative, relying on chemotherapy and radiation therap...
lymphoid neoplasms has been reported as reproducible among expert pathologists and feasible in a com...
IF 1.126 (2016)International audienceIn this review, we report the main advances of the last years i...
The authors present the guiding principles which led to the development of the Revised European Amer...
The classification of malignant lymphomas remained controversial for over 30 years. The first scheme...
The recently proposed Revised European-American Lymphoma Classification represents a serious attempt...
Background. Lymphoma management has traditionally been dominated by nodal histopathology. Unfortunat...
In 1991, a group of experienced European and American haematopathologists, none of whom had previous...
International audienceDifferent histopathologic classifications have been used in the study of malig...
To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferen...
To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferen...
To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferen...
Zachary H Word1, Matthew J Matasar1,21Lymphoma Service, Department of Medicine, Memorial Sloan&n...
Non-Hodgkin’s lymphomas (NHL)account for 4 % of all cancers:1 ofthese, about 40 % are indolent NHL, ...
Malignant lymphoma and other lymphoproliferative disorders represent a group of malignant hemopathie...
Therapy of the lymphomas is predominantly nonoperative, relying on chemotherapy and radiation therap...
lymphoid neoplasms has been reported as reproducible among expert pathologists and feasible in a com...
IF 1.126 (2016)International audienceIn this review, we report the main advances of the last years i...
The authors present the guiding principles which led to the development of the Revised European Amer...
The classification of malignant lymphomas remained controversial for over 30 years. The first scheme...
The recently proposed Revised European-American Lymphoma Classification represents a serious attempt...
Background. Lymphoma management has traditionally been dominated by nodal histopathology. Unfortunat...
In 1991, a group of experienced European and American haematopathologists, none of whom had previous...
International audienceDifferent histopathologic classifications have been used in the study of malig...
To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferen...
To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferen...
To complete the existing treatment guidelines for all tumor types, ESMO organizes consensus conferen...
Zachary H Word1, Matthew J Matasar1,21Lymphoma Service, Department of Medicine, Memorial Sloan&n...
Non-Hodgkin’s lymphomas (NHL)account for 4 % of all cancers:1 ofthese, about 40 % are indolent NHL, ...
Malignant lymphoma and other lymphoproliferative disorders represent a group of malignant hemopathie...
Therapy of the lymphomas is predominantly nonoperative, relying on chemotherapy and radiation therap...
lymphoid neoplasms has been reported as reproducible among expert pathologists and feasible in a com...
IF 1.126 (2016)International audienceIn this review, we report the main advances of the last years i...